跳至主要内容
临床试验/NCT07421895
NCT07421895招募中不适用

A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

The Third Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2022年6月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
600
试验地点
1
主要终点
Number of Participants with Intrauterine Adhesions (IUA) at 3 Months Post-Treatment

研究概览

简要总结

The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Clinical diagnosis of retained products of conception, and ultrasound indicated that the maximum diameter of the lesion ≥0.5cm.

排除标准

  • There is active bleeding requiring immediate surgical intervention;2) combined with obvious infection;3) Combined with severe organ dysfunction, including coagulation dysfunction.

研究组 & 干预措施

Control group

After the patient is confirmed to be included in the study, he/she will be hospitalized directly and will undergo hysteroscopic removal of pregnancy products.

干预措施: Uterine curettage (Procedure)

Experimental group

Wait until a certain time, then surgical treatment if necessary

干预措施: Expectant care (Drug)

结局指标

主要结局

Number of Participants with Intrauterine Adhesions (IUA) at 3 Months Post-Treatment

时间窗: At 3 months after completion of treatment (on the 16th-24th day of the third menstrual cycle post-treatment)

Intrauterine adhesions are diagnosed by three-dimensional transvaginal ultrasound or hysteroscopy. Adhesions are graded according to the American Fertility Society (AFS) classification. This outcome measures the incidence of IUA following different management strategies for retained products of conception, reflecting the degree of endometrial injury.

Number of Participants Requiring Secondary Surgical Evacuation

时间窗: From initiation of treatment to 3 months post-treatment

Secondary surgical evacuation is defined as any additional surgical procedure (hysteroscopic or curettage) required for complete removal of retained products of conception after the initial management strategy. This outcome reflects the effectiveness of the initial treatment approach and the number of intrauterine procedures.

Number of Participants Achieving Pregnancy within 1 Year after Attempting Conception

时间窗: From the start of attempting pregnancy (after completion of treatment and at least one normal menstrual cycle) up to 1 year

Pregnancy is defined as a positive serum β-hCG test and confirmed intrauterine gestational sac by ultrasound. This outcome is assessed only in participants with fertility intent and reflects the ultimate goal of fertility preservation.

次要结局

  • Number of Participants with Active Bleeding During Expectant Management(From enrollment to hospitalization or intervention, assessed up to 3 months)
  • Number of Participants with Pelvic Infection During Expectant Management(From enrollment to hospitalization or intervention, assessed up to 3 months)
  • Number of Participants with Live Birth Following Subsequent Pregnancy(At delivery, assessed up to 1 year after pregnancy confirmation)
  • Intraoperative Blood Loss During Hysteroscopic Surgery(During the surgical procedure)
  • Endometrial Thickness at 3 Months Post-Treatment(At 3 months after treatment (on the 16th-24th day of the third menstrual cycle post-treatment))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu dabao

MD

The Third Xiangya Hospital of Central South University

研究点 (1)

Loading locations...

相似试验